Hem6: An ENU-induced recessive hypochromic microcytic anemia mutation in the mouse

Blood

Volumn 112, Issue 10, 2008, Pages 4308-4313

  Tian, Meng ^b   Campagna, Dean R ^b   Woodward, Lanette S ^c   Justice, Monica J ^c   Fleming, Mark D ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINOLEVULINATE SYNTHASE; ETHYLNITROSOUREA; HEMOPROTEIN; PROTEIN HEM6; PROTOPORPHYRIN ZINC; UNCLASSIFIED DRUG; HEME; IRON;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ASSAY; ERYTHROPOIETIC PROTOPORPHYRIA; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; IRON TRANSPORT; MALE; MICROCYTIC ANEMIA; MOUSE; MOUSE MUTANT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RETICULOCYTE; ANIMAL; BIOSYNTHESIS; CROSS BREEDING; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HEMATOPOIESIS; IRON DEFICIENCY ANEMIA; METABOLISM; PATHOLOGY;

5-AMINOLEVULINATE SYNTHETASE; ANEMIA, HYPOCHROMIC; ANIMALS; CROSSES, GENETIC; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEMATOPOIESIS; HEME; IRON; MALE; MICE; MICE, MUTANT STRAINS; PROTOPORPHYRIA, ERYTHROPOIETIC; RETICULOCYTES;

EID: 58149143299     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2007-09-111500     Document Type: Article

References (41)

1. Ney PA. Gene expression during terminal erythroid differentiation. Curr Opin Hematol. 2006; 13:203-208.
2. Ingley E, Tilbrook PA, Klinken SP. New insights into the regulation of erythroid cells. IUBMB Life. 2004;56:177-184.
3. Petrak J, Myslivcova D, Man P, Cmejlova J, Cmejla R, Vyoral D. Proteomic analysis of erythroid differentiation induced by hexamethylene bisacetamide in murine erythroleukemia cells. Exp Hematol. 2007;35:193-202.
4. Andrews NC. Animal models of hereditary iron transport disorders. Adv Exp Med Biol. 2002;509: 1-17.
5. Ponka P. Tissue-specific regulation of iron metabolism and heme synthesis: distinct control mechanisms in erythroid cells. Blood. 1997;89:1-25.
6. Ajioka RS, Phillips JD, Kushner JP. Biosynthesis of heme in mammals. Biochim Biophys Acta. 2006;1763:723-736.
7. Sadlon TJ, Dell'Oso T, Surinya KH, May BK. Regulation of erythroid 5-aminolevulinate synthase expression during erythropoiesis. Int J Biochem Cell Biol. 1999;31:1153-1167.
8. Romeo PH, Raich N, Dubart A, et al. Molecular cloning and nucleotide sequence of a complete human uroporphyrinogen decarboxylase cDNA. J Biol Chem. 1986;261:9825-9831.
9. Wingert RA, Galloway JL, Barut B, et al. Deficiency of glutaredoxin 5 reveals Fe-S clusters are required for vertebrate haem synthesis. Nature. 2005;436:1035-1039.
10. Napier I, Ponka P, Richardson DR. Iron trafficking in the mitochondrion: novel pathways revealed by disease. Blood. 2005;105:1867-1874.
11. Rouault TA, Tong WH. Iron-sulphur cluster biogenesis and mitochondrial iron homeostasis. Nat Rev Mol Cell Biol. 2005;6:345-351.
12. Dailey HA, Sellers VM, Dailey TA. Mammalian ferrochelatase: expression and characterization of normal and two human protoporphyric ferrochelatases. J Biol Chem. 1994;269:390-395.
13. Harford JB, Rouault TA, Huebers HA, Klausner RD. Molecular mechanisms of iron metabolism. In: Stamatoyannopoulos G, Nienhuis AW, Majerus PW, Varmus H, eds. The Molecular Basis of Blood Diseases. Philadelphia: W.B. Saunders Co. 1994:351-378.
14. Ohgami RS, Campagna DR, Antiochos B, et al. nm1054: a spontaneous, recessive, hypochromic, microcytic anemia mutation in the mouse. Blood. 2005;106:3625-3631.
15. Ohgami RS, Campagna DR, Greer EL, et al. Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells. Nat Genet. 2005;37:1264-1269.
16. Ohgami RS, Campagna DR, McDonald A, Fleming MD. The Steap proteins are metalloreductases. Blood. 2006;108:1388-1394.
17. Fleming MD, Romano MA, Su MA, Garrick LM, Garrick MD, Andrews NC. Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport. Proc Natl Acad Sci U S A. 1998;95:1148-1153.
18. Fleming MD, Trenor CC 3rd, Su MA, et al. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat Genet. 1997;16:383-386.
19. Gunshin H, Mackenzie B, Berger UV, et al. Cloning and characterization of a mammalian protoncoupled metal-ion transporter. Nature. 1997;388: 482-488.
20. Shaw GC, Cope JJ, Li L, et al. Mitoferrin is essential for erythroid iron assimilation. Nature. 2006; 440:96-100.
21. Sheftel AD, Zhang AS, Brown C, Shirihai OS, Ponka P. Direct interorganellar transfer of iron from endosome to mitochondrion. Blood. 2007; 110:125-132.
22. Kile BT, Hentges KE, Clark AT, et al. Functional genetic analysis of mouse chromosome 11. Nature. 2003;425:81-86.
23. Eppig JJ, Kozak LP, Eicher EM, Stevens LC. Ovarian teratomas in mice are derived from oocytes that have completed the first meiotic division. Nature. 1977;269:517-518.
24. Sinclair P, Granick S. Two methods for determining the activity of delta-aminolevulinate synthetase within intact liver cells in culture. Anal Biochem. 1977;79:380-393.
25. Han AP, Fleming MD, Chen JJ. Heme-regulated eIF2alpha kinase modifies the phenotypic severity of murine models of erythropoietic protoporphyria and beta-thalassemia. J Clin Invest. 2005; 115:1562-1570.
26. Manly KF, Cudmore RH Jr, Meer JM. Map Manager QTX, cross-platform software for genetic mapping. Mamm Genome. 2001;12:930-932.
27. Labbe R, Vreman H, Stevenson D. Zinc protoporhyrin: a metabolite with a mission. Clin Chem. 1999;45:2060-2072.
28. Garrick LM, Gniecko K, Hoke JE, al-Nakeeb A, Ponka P, Garrick MD. Ferric-salicylaldehyde isonicotinoyl hydrazone, a synthetic iron chelate, alleviates defective iron utilization by reticulocytes of the Belgrade rat. J Cell Physiol. 1991; 146:460-465.
29. Tutois S, Montagutelli X, Da Silva V, et al. Erythropoietic protoporphyria in the house mouse. A recessive inherited ferrochelatase deficiency with anemia, photosensitivity, and liver disease. J Clin Invest. 1991;88:1730-1736.
30. Bottomley SS, May BK, Cox TC, Cotter PD, Bishop DF. Molecular defects of erythroid 5-aminolevulinate synthase in X-linked sideroblastic anemia. J Bioenerg Biomembr. 1995;27:161-168.
31. Fleming MD. The genetics of inherited sideroblastic anemias. Semin Hematol. 2002;39:270-281.
32. Cartwright GE, Deiss A. Sideroblasts, siderocytes, and sideroblastic anemia. N Engl J Med. 1975;292:185-193.
33. Nakajima O, Takahashi S, Harigae H, et al. Heme deficiency in erythroid lineage causes differentiation arrest and cytoplasmic iron overload. EMBO J. 1999;18:6282-6289.
34. Harigae H, Nakajima O, Suwabe N, et al. Aberrant iron accumulation and oxidized status of erythroid- specific delta-aminolevulinate synthase (ALAS2)-deficient definitive erythroblasts. Blood. 2003;101:1188-1193.
35. Keyhani M, Giuliani D, Giuliani ER, Morse BS. Erythropoiesis in pyridoxine deficient mice. Proc Soc Exp Biol Med. 1974;146:114-119.
36. Gardner LC, Cox TM. Biosynthesis of heme in immature erythroid cells: the regulatory step for heme formation in the human erythron. J Biol Chem. 1988;263:6676-6682.
37. Cox TC, Bawden MJ, Martin A, May BK. Human erythroid 5'-aminolevulinate synthase: promoter analysis and identification of an iron-responsive element in the mRNA. EMBO J. 1991;10:1891.
38. Dandekar T, Stripecke R, Gray NK, et al. Identification of a novel iron-responsive element in murine and human erythroid delta-aminolevulinic acid synthase mRNA. EMBO J. 1991;10:1903-1909.
39. Conboy JG, Cox TC, Bottomley SS, Bawden MJ, May BK. Human erythroid 5-aminolevulinate synthase: gene structure and species-specific differences in alternative RNA splicing. J Biol Chem. 1992;267:18753-18758.
40. Surinya KH, Cox TC, May BK. Transcriptional regulation of the human erythroid 5-aminolevulinate synthase gene: identification of promoter elements and role of regulatory proteins. J Biol Chem. 1997;272:26585-26594.
41. Surinya KH, Cox TC, May BK. Identification and characterization of a conserved erythroid-specific enhancer located in intron 8 of the human 5-aminolevulinate synthase 2 gene. J Biol Chem. 1998; 273:16798-16809.